The implications of the expanded use of “national security letters” by the FBI and other agencies to compel disclosure of business record information will be explored in a hearing tomorrow before the Senate Judiciary Committee.
For an introduction to the subject see “National Security Letters in Foreign Intelligence Investigations: Legal Background and Recent Amendments” (pdf), Congressional Research Service, updated March 28, 2008.
Next week on April 30, Sen. Russ Feingold will chair a Senate Judiciary subcommittee hearing on “Secret Law and the Threat to Democratic and Accountable Government.”
Improving public awareness of FDA Advisory Committees would improve public trust and deter misinformation related to the approval of medical products.
FAS has been a leading voice for action on this topic, and has developed a compendium of 150+ heat-related federal policy recommendations.
Proposed bills advance research ecosystems, economic development, and education access and move now to the U.S. House of Representatives for a vote
The absence of consistent voting privileges for patient representatives on Advisory Committees hinders representatives from providing an voice on behalf of the community they represent.